Ting Bei

466 total citations
14 papers, 155 citations indexed

About

Ting Bei is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Ting Bei has authored 14 papers receiving a total of 155 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in Ting Bei's work include Cancer Immunotherapy and Biomarkers (3 papers), Cancer Genomics and Diagnostics (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Ting Bei is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), Cancer Genomics and Diagnostics (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Ting Bei collaborates with scholars based in China, Ethiopia and United States. Ting Bei's co-authors include Yuezong Bai, Xiaochen Zhao, Bei Zhang, Chen Chen, Zhenfa Zhang, Shiqing Chen, Bin Zhang, Dongsheng Yue, Yuchen Ma and Tao Zhang and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and International Journal of Cancer.

In The Last Decade

Ting Bei

13 papers receiving 154 citations

Peers

Countries citing papers authored by Ting Bei

Since Specialization

Citations

This map shows the geographic impact of Ting Bei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ting Bei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ting Bei more than expected).

Fields of papers citing papers by Ting Bei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ting Bei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ting Bei. The network helps show where Ting Bei may publish in the future.

Co-authorship network of co-authors of Ting Bei

This figure shows the co-authorship network connecting the top 25 collaborators of Ting Bei. A scholar is included among the top collaborators of Ting Bei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ting Bei. Ting Bei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Association between homologous recombination deficiency and outcomes with platinum and platinum-free chemotherapy in patients with triple-negative breast cancer 2023 ·Cancer Biology and Medicine ·(unknown), Xue Wang, Feng Du, Jian Yue, Yiran Si, Xiaochen Zhao, Lina Cui, Bei Zhang, Ting Bei, Binghe Xu, Peng Yuan	7
2	Chromosome 11q13 amplification correlates with poor response and prognosis to PD-1 blockade in unresectable hepatocellular carcinoma 2023 ·Frontiers in Immunology ·Kai Yan, Ding Zhang, Yanan Chen, Wenfeng Lu, Mengli Huang, Jinping Cai, Shiqing Chen, Ting Bei, Yuezong Bai, (unknown), Yong Fu, Haibin Zhang	3
3	China special issue on gastrointestinal tumors—NTRK fusion in a large real‐world population and clinical utility of circulating tumor DNA genotyping to guide TRK inhibitor treatment 2023 ·International Journal of Cancer ·Changsong Qi, (unknown), Yuezong Bai, Hui Chen, Jiajia Yuan, Feilong Zhao, Chang Liu, Mingyang Ma, Ting Bei, Shiqing Chen, Xiaochen Zhao, Chunzhu Chen, Lin Shen	2
4	Tumor immune microenvironment changes are associated with response to neoadjuvant chemotherapy and long-term survival benefits in advanced epithelial ovarian cancer: A pilot study 2023 ·Frontiers in Immunology ·Guangming Cao, (unknown), Jinfeng Li, Bin Zhang, Zhiqiang Zhang, Bei Zhang, Ting Bei, (unknown), Shiqing Chen, Shuzhen Wang, Lei Zhu	9
5	Intensive cycles of neoadjuvant camrelizumab combined with chemotherapy in locally advanced esophageal squamous cell carcinoma: a single-arm, phase II trial 2023 ·Journal of Translational Medicine ·(unknown), Xiaodong Su, (unknown), Guangyu Luo, Zhiqiang Wang, Peiqiang Cai, Yating Zheng, Ting Bei, Mengli Huang, Yuezong Bai, Haoqiang He, Jin Xiang, Muyan Cai, Jiudi Zhong, (unknown), (unknown)	17
6	Landscape of RB1 alterations in 22,432 Chinese solid tumor patients 2022 ·Annals of Translational Medicine ·(unknown), Jiyang Zheng, Shu Wang, Yuhao Wang, Guixiang Li, Nan Wang, (unknown), Wei‐Ming Duan, Hushan Zhang, Depei Huang, Ting Bei, Dan Fu, Jianjun Yang	3
7	Tumor microenvironment features decipher the outperformance of neoadjuvant immunochemotherapy over chemotherapy in resectable non-small cell lung cancer 2022 ·Frontiers in Immunology ·(unknown), Jing Miao, (unknown), Ting Bei, Xiaochen Zhao, Shiqing Chen, (unknown), (unknown), Chongchong Wu, Zhiqiang Xue	9
8	Circulating tumor DNA predicts neoadjuvant immunotherapy efficacy and recurrence-free survival in surgical non-small cell lung cancer patients 2022 ·Translational Lung Cancer Research ·Dongsheng Yue, Weiran Liu, Chen Chen, Tao Zhang, Yuchen Ma, Longgang Cui, Yajun Gu, Ting Bei, Xiaochen Zhao, Bei Zhang, Yuezong Bai, Atocha Romero, Meng Xu‐Welliver, Changli Wang, Zhenfa Zhang, Bin Zhang	63
9	Next-generation sequencing based detection of BRCA1 and BRCA2 large genomic rearrangements in Chinese cancer patients 2022 ·Frontiers in Oncology ·(unknown), Qiu‐Hong Tian, Xue Wang, Ting Bei, Lina Cui, Bei Zhang, (unknown), Yuezong Bai, Xiaochen Zhao, Peng Yuan	4
10	Special issue “The advance of solid tumor research in China”: FGFR4 alterations predict efficacy of immune checkpoint inhibitors in nonsmall cell lung cancer 2022 ·International Journal of Cancer ·Guanghui Gao, Longgang Cui, Fei Zhou, Tao Jiang, Wanying Wang, Shiqi Mao, Fengying Wu, (unknown), Bei Zhang, Ting Bei, (unknown), Cheng Zhang, (unknown), Chan Gao, Xiaochen Zhao, Yuezong Bai, Caicun Zhou, Shengxiang Ren	3
11	Pyrotinib in Patients with HER2-Amplified Advanced Non–Small Cell Lung Cancer: A Prospective, Multicenter, Single-Arm Trial 2021 ·Clinical Cancer Research ·Zhengbo Song, Dongqing Lv, Shiqing Chen, Jianjin Huang, Yuping Li, Shenpeng Ying, Xiaoyu Wu, Feng Hua, Wenxian Wang, C. Xu, Ting Bei, Chan Gao, Zhijian Sun, Yiping Zhang, Shun Lü	31
12	Prevalence of hyperprogressive disease (HPD) mutations and correlations to immune-related biomarkers in a large pan-cancer Chinese cohort. 2021 ·Journal of Clinical Oncology ·Shengli Yang, Xinyi Liu, Ting Bei, Mengli Huang	1
13	RECQL5 mutations as a potential efficacious predictor of immunotherapy in melanoma patients. 2021 ·Journal of Clinical Oncology ·Yun Zhao, Dandan Fan, Xiaochun Huang, Mengli Huang, Yaoxu Chen, Ting Bei	0
14	Neoadjuvant programmed death-1 blockade plus chemotherapy in locally advanced esophageal squamous cell carcinoma. 2021 ·Journal of Clinical Oncology ·Xu Zhang, (unknown), Xiaodong Su, Guangyu Luo, Peiqiang Cai, Yating Zheng, Ting Bei, Chan Gao, Mengli Huang	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact